CSS
CVS icon

Cubist Systematic Strategies’s CVS Health CVS Stock Holding History

Cubist Systematic Strategies’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$19.2M Sell
254,600
-62,400
-20% -$4.28M 0.09% 294
2025
Q2 		$21.9M Sell
317,000
-304,700
-49% -$20M 0.1% 265
2025
Q1 		$42.1M Sell
621,700
-74,600
-11% -$4.46M 0.25% 47
2024
Q4 		$31.3M Buy
696,300
+482,900
+226% +$27.1M 0.2% 81
2024
Q3 		$13.4M Sell
213,400
-129,800
-38% -$7.57M 0.08% 336
2024
Q2 		$20.3M Buy
343,200
+190,500
+125% +$11.9M 0.14% 154
2024
Q1 		$12.2M Sell
152,700
-194,900
-56% -$14.9M 0.07% 394
2023
Q4 		$27.4M Buy
347,600
+70,000
+25% +$4.98M 0.18% 71
2023
Q3 		$19.4M Sell
277,600
-16,000
-5% -$1.13M 0.14% 128
2023
Q2 		$20.3M Sell
293,600
-69,500
-19% -$4.95M 0.13% 118
2023
Q1 		$27M Buy
363,100
+133,300
+58% +$11.2M 0.16% 82
2022
Q4 		$21.4M Buy
229,800
+13,500
+6% +$1.3M 0.12% 137
2022
Q3 		$20.6M Buy
216,300
+47,800
+28% +$4.73M 0.12% 143
2022
Q2 		$15.6M Buy
+168,500
New +$16.4M 0.1% 219

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cubist Systematic Strategies's CVS Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of CVS Health (CVS) in Q1 2025, closing a stake of 459,045 shares — an estimated $27.5M sold.

Cubist Systematic Strategies first reported a position in CVS in Q2 2014 and held it in 39 quarters. The position peaked at $73.7M in Q1 2023. 1,752 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 459,045 CVS Health shares in Q1 2025, an estimated $27.5M.
  • Cubist Systematic Strategies first reported a position in CVS Health in Q2 2014 and held it in 39 quarters.
  • Cubist Systematic Strategies's CVS Health position peaked at $73.7M in Q1 2023.
  • 1,752 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.